Detecting Fraud and Anti-Competitive Behaviour in the Australian Pharmaceutical and Medical Device Industries

该项目将提出法律改革建议，以确保加强问责，并减少与每年根据药品福利计划(PBS)花费的60多亿美元公款以及公立医院在医疗设备上支付的巨额费用相关的欺诈和反竞争行为。它将澳大利亚药品监管和高科技执法方面的专家与一名著名的美国合作伙伴调查员联合起来，进行虚假索赔诉讼。减少欺诈和反竞争行为可能对公共广播公司的生存及其带来的好处至关重要，特别是对老龄化人口而言。

This Project will deliver law reform proposals to ensure greater accountability and a reduction of fraud and anti-competitive behaviour associated with over 6 billion dollars of public money expended each year under the Pharmaceutical Benefits Scheme (PBS) as well as significant amounts paid by public hospitals on medical devices. It unites experts in Australian pharmaceutical regulation and high technology law enforcement with an eminent United States Partner Investigator in False Claims litigation. Reducing fraud and anti-competitive behaviour could be critical to survivability of the PBS and the benefits it brings particularly to an ageing population.